Prot# I1F-MC-RHAZ: A Multicenter Study with a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Maintenance Dosing Period and a Long-Term Extension Period to Evaluate the Efficacy and Safety of LY2439821 in Pati

Project: Research project

Project Details

Effective start/end date4/30/1211/30/19


  • Parexel (I1F-MC-RHAZ // I1F-MC-RHAZ)
  • Eli Lilly and Company (I1F-MC-RHAZ // I1F-MC-RHAZ)